Zhang et al. re-evaluated 281 breast cancer cases diagnosed at a single institution and observed inter-observer variations in evaluating HER2 IHC staining, particularly in IHC 0 and IHC 1+ [23]. Here, ERBB2 is linked to breast carcinoma.